What is Acadia Pharmaceuticals's price / earnings?

Acadia Pharmaceuticals (ACAD) reported price / earnings of 10.1× in Q1 2026.

How has Acadia Pharmaceuticals's price / earnings changed year-over-year?

Acadia Pharmaceuticals's price / earnings decreased by 16.5% year-over-year, from 12.1× to 10.1×.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Acadia Pharmaceuticals ACAD Price / earnings

Price / earnings at other companies

BiogenBIIB

18.9×+5.4×

Neurocrine BiosciencesNBIX

19.8×-16.3×

Catalyst PharmaceuticalCPRX

13.7×-1.3×

PTC TherapeuticsPTCT

6.5×—

TG TherapeuticsTGTX

11.5×-147×

Arrowhead ResearchARWR

44.6×—

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

market cap/net income=10.1×

Based on the most recent quarter.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's price / earnings?: Acadia Pharmaceuticals (ACAD) reported price / earnings of 10.1× in Q1 2026.
How has Acadia Pharmaceuticals's price / earnings changed year-over-year?: Acadia Pharmaceuticals's price / earnings decreased by 16.5% year-over-year, from 12.1× to 10.1×.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.